US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Abstract, Snapshot, Market Analysis & Market Definition: Global Postoperative Pain Therapeutics Service Market More than 75% of patients undergoing surgery suffer from acute pain. Postoperative pain is defined as a condition of tissue injury together with muscle spasm after surgery. Recently, peripheral and central sensitization has been shown within the mechanisms of postoperative pain generation. In 2020, the global Postoperative Pain Therapeutics Service market size was million US$ and it is expected to reach xx million US$ by the end of 2029, with a CAGR of xx% during 2020-2029. This report focuses on the global Postoperative Pain Therapeutics Service status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Postoperative Pain Therapeutics Service development in United States, Europe, and Asia-Pacific. Market Segmentation: Global Postoperative Pain Therapeutics Service Market Segmentation by Product Type: Breakdown of data from the year 2015 to 2020 and forecast until 2029:
Segmentation by Application: Breakdown of data from the year 2015 to 2020 and forecast until 2029:
- Local Anesthetics
- Tricyclic Antidepressants
- Antiepileptic Drugs
Top Companies & Key Players: Global Postoperative Pain Therapeutics Service Market The report offers a detailed analysis of several leading Postoperative Pain Therapeutics Service manufacturers including:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
In October 2020, Heron Therapeutics, B.V. received marketing authorization valid throughout the European Union for Zynrelef, which is a painkiller used in adults to reduce pain from small to medium-sized wounds after an operation. Zynrelef is a prolonged-release solution that is applied to the wound during surgery before the wound is closed. Prolonged-release means that the active substances are released slowly over several hours after application. It utilizes a novel, synergistic mechanism of action that combines bupivacaine with a low dose of the nonsteroidal anti-inflammatory drug (NSAID) meloxicam. Bupivacaine is a local anesthetic that temporarily numbs the area to which it has been applied by blocking pain signals to the brain. Meloxicam, a non-steroidal anti-inflammatory drug (NSAID), reduces pain and inflammation and strengthens the effect of bupivacaine. It has been shown to provide effective pain relief from small to medium-sized wounds after surgery. Its effect on reducing the need for opioid pain relief was considered modest but clinically significant. Heron's New Drug Submission (NDS) for HTX-011 for the management of postoperative pain was granted Priority Review status by Health Canada in October 2019 and accepted by Health Canada in November 2019. Heron is working to respond to a list of questions received from Health Canada in July 2020. Key Insights Covered: Global Postoperative Pain Therapeutics Service Market 1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Postoperative Pain Therapeutics Service industry. 2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Postoperative Pain Therapeutics Service industry. 3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Postoperative Pain Therapeutics Service industry. 4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Postoperative Pain Therapeutics Service industry. 5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Postoperative Pain Therapeutics Service industry. Research Methodology: Global Postoperative Pain Therapeutics Service Market
- Mallinckrodt Pharmaceuticals
- Trevena, Inc.
- Heron Therapeutics
- Pacira BioSciences, Inc.
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly & Company
- Bayer AG
- Novartis AG
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other
Table of Contents 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Postoperative Pain Therapeutics Service Market Size Growth Rate by Type (2014-2025) 1.4.2 Opioids 1.4.3 NSAIDS 1.4.4 Local Anesthetics 1.4.5 Tricyclic Antidepressants 1.4.6 Antiepileptic Drugs 1.4.7 Other 1.5 Market by Application 1.5.1 Global Postoperative Pain Therapeutics Service Market Share by Application (2014-2025) 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered2 Global Growth Trends 2.1 Postoperative Pain Therapeutics Service Market Size 2.2 Postoperative Pain Therapeutics Service Growth | read more...